课题基金 / 基金详情

项目摘要

项目成果

Kewen Cai的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Fundamentally, angiogenesis plays a key role in the growth and development of new tissues. In the case of a tumor, however, angiogenesis becomes the primary facilitator of rapid tumor growth and metastasis. As a result, angiogenesis inhibition has become an area of increased focus for researchers and pharmaceutical companies seeking to develop new methods of cancer treatment. Traditionally, the gold-standard technique to quantify tumor vasculature has been the histological estimate of microvascular density (MVD). This method, however, is inherently invasive, time consuming, and suffers from sampling bias. To overcome these limitations, researchers turned to MR tumor vasculature imaging. Some of the most successful reported techniques such as Dynamic Contrast Enhanced (DCE) MRI employ exogenous contrast agents. Methods based on the endogenous contrast, such as Arterial Spin Labeling (ASL) and Blood Oxygen Level Dependent (BOLD) MRI induced by carbogen/hyperoxic challenges were also investigated. These methods, however, do not provide sufficient sensitivity for high-resolution imaging of tumor vasculature. In this study, we carefully induced hypoxia challenge (8% oxygen inhalation) to generate sufficient BOLD contrast (~40%), with which high-resolution tumor vasculature maps were able to be obtained. 3D high-resolution tumor vasculature maps can be acquired in minutes. This technique may provide an efficient research tool for us to quantify tumor size, measure tumor vasculature density, provide early detection of tumor metastasis, monitor the effectiveness of cancer treatment drugs, and could potentially characterize tumor grade and aggressiveness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRI OF ANGIOGENESIS AND VASCULATURE ALTERNATIONS IN ALZHEIMER'S DISEASE
  • 批准号:
    8362004
  • 项目类别:
  • 资助金额:
    $0.77万
  • 财政年份:
    2011
  • 负责人:
    Kewen Cai
  • 依托单位:
CEST AND T1RHO MRI OF LIVER FIBROSIS
  • 批准号:
    8361974
  • 项目类别:
  • 资助金额:
    $3.84万
  • 财政年份:
    2011
  • 负责人:
    Kewen Cai
  • 依托单位:
MAGNETIC RESONANCE IMAGING OF THE NEUROTRANSMITTER GABA AND GLUTAMATE IN VIVO
  • 批准号:
    8361973
  • 项目类别:
  • 资助金额:
    $3.84万
  • 财政年份:
    2011
  • 负责人:
    Kewen Cai
  • 依托单位:
MAGNETIC RESONANCE IMAGING OF THE NEUROTRANSMITTER GABA AND GLUTAMATE IN VIVO
  • 批准号:
    8169062
  • 项目类别:
  • 资助金额:
    $4.34万
  • 财政年份:
    2010
  • 负责人:
    Kewen Cai
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: